SCHEMBL26414604

SCHEMBL26414604

COc1cc(-c2c(C)n[nH]c2C)ccc1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.57
ALDH1A1 P00352 2/20 0.57
BRD4 O60885 4/20 0.51
BRD3 Q15059 1/20 0.51
CHEK1 O14757 1/20 0.50
AKT2 P31751 1/20 0.50
LMNA P02545 2/20 0.48
POLB P06746 1/20 0.48
ROCK2 O75116 1/20 0.47
ROCK1 Q13464 1/20 0.47
MAPT P10636 2/20 0.47
TSHR P16473 1/20 0.47
ALOX12 P18054 1/20 0.47
MAPK1 P28482 1/20 0.47
HSD17B10 Q99714 1/20 0.47
ACVR1 Q04771 1/20 0.45
DHFR P00374 1/20 0.41
MKNK1 Q9BUB5 2/20 0.41
MKNK2 Q9HBH9 1/20 0.41
BRD2 P25440 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3083270 0.81 KDM4E (0.51) KDM4EALDH1A1BRD4BRD3CHEK1
SCHEMBL5259632 0.77 S1PR1 (0.49) KDM4EALDH1A1HSD17B10S1PR1
SCHEMBL27685100 0.77 CHEK1 (0.53) KDM4EALDH1A1BRD4CHEK1AKT2
SCHEMBL16209719 0.76 AKT2 (0.79) KDM4EALDH1A1BRD4BRD3CHEK1
SCHEMBL16005913 0.76 ROCK2 (0.54) KDM4EALDH1A1BRD4BRD3CHEK1
SCHEMBL24765276 0.74 CHEK1 (0.59) ALDH1A1CHEK1AKT2LMNAROCK2
SCHEMBL9440147 0.74 ALDH1A1 (0.56) ALDH1A1TSHRHSD17B10DHFRS1PR1
SCHEMBL4863136 0.73 KDM4E (0.64) KDM4EALDH1A1LMNAPOLBMAPT
SCHEMBL17117158 0.72 ALDH1A1 (0.54) ALDH1A1TSHRHSD17B10DHFRS1PR1
SCHEMBL21262737 0.71 AKT2 (0.70) ALDH1A1BRD4CHEK1AKT2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023072962-A1 SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS Yukin Therapeutics (FR) 2023-05-04 WO disclosed
EP-4169904-A1 SUBSTITUTED QUINOLINES AS IMPROVED NF-KB-INDUCING KINASE (NIK) INHIBITORS Yukin Therapeutics (FR) 2023-04-26 EP disclosed